Table 1

Clinical and demographic characteristics of children with primary congenital and adults with open-angle glaucoma at inclusion in study

IDAge (years)SexEthnicityAffected eyeVision (logMAR)Refraction (SE)IOPCorneal diameter (mm)Cup:disc ratioSurgical treatment
RELERELERELERELERELE
A. Primary congenital glaucoma
110.3MABE0.00−0.06PlanoPlano161812120.40.3G(BE)
29.3MABE1.300.08−9.00−1.00202012.5110.40.3G(BE×2)
30.8FCBE0.98 (PL)FF (PL)−2.75−1.75222014100.30.2G(BE), TRAB(LE)
44.3MCBE0.130.13−0.25−0.50152112120.350.5G(BE), TRAB(RE)
52.1FCBE1.10 (CC)1.10 (CC)+1.00Plano141614140.10.1G(BE), BT(RE)
63.7FABE0.40 (CC)0.40 (CC)+0.50−0.50202013130.80.8G(BE)
75.8FABE0.430.70−6.25−1.00141214130.50.5TRAB(BE)
88.0FABE0.220.64−1.501.00121211130.50.5TRAB(BE×2RE)
93.6FABE0.200.20+1.75−2.7561114130.50.5G(BE)
101.5MCRE0.80 (CC)0.70 (CC)−0.25+2.25161412110.50.5G(RE×2)
110.4MCBE0.86 (PL)0.64 (PL)−1.00−1.50292512130.50.5Listed for surgery
125.7MCBE0.150.13−1.00−1.008813130.70.4G(BE)
131.6MCLE0.10 (PL)0.70 (PL)−1.00Plano141210130.30.6G(LE×2)
143.6MCRE0.950.30−11.00−0.2518813100.80.3G(RE)
152.9FALE0.351.061.25−3.50182010120.20.45G(LE)
165.0FARE1.83−0.05−3.00+0.75141612100.20.2G(RE×2), CL(RE)
172.3FCBE0.510.51−1.251.50231223120.20.2G(RE)
185.1MCLE0.08LP+0.25−7.0028129120.20.9G(LE×3)
197.2MCBE1.150.08+2.25+2.2530181212.50.80.9G(BE), TRAB(BE)
206.7FCBE0.100.10−1.00−1.00252314130.40.9G(BE)
212.1MCBE0.80.7−0.50+1.25141610120.40.4G(BE)
220.8MALEFFFF+1.00−3.00122010120.40.7G(LE), TRAB(LE)
234.1FABE0.40.4PlanoPlano161612120.50.5G(BE)
242.0MABEFFFF19201211Listed for surgery
B. Healthy children (controls for primary congenital glaucoma)
10.4FC0.4 (PL)0.4 (PL)PlanoPlano121210.510.50.30.3
20.5MC0.3 (PL)0.3 (PL)+2.00+2.00141311110.20.2
30.7FC0.4 (PL)0.4 (PL)+3.25+3.00111210.810.80.30.3
40.8FC0.3 (PL)0.3 (PL)+2.50+2.50141411110.30.3
50.8MAFFFF+2.50+2.50121411110.30.3
610MA0.30.3PlanoPlano161611.211.20.350.35
73FC0.1 (CC)0.1 (CC)+1.25+1.25161711110.20.2
84FA0.000.00+1.00+1.00161611110.30.3
97FA0.100.10PlanoPlano171611110.30.3
104MC0.2 (CC)0.2 (CC)+0.75+0.75181811110.30.3
116.4MC0.150.13PlanoPlano151510100.30.3
125.5MC0.100.10PlanoPlano161811110.30.3
132FA0.3 (CC)0.3 (CC)+1.25+1.25161411110.30.3
144MC0.200.20+1.00+1.00161611110.30.3
155FA0.100.10+1.25+1.25181811110.20.2
165MC0.000.00+0.50+0.75161611110.20.2
171.5MC0.2 (PL)0.2 (PL)+0.75+0.75181811110.30.3
184MA0.100.10+2.00+2.00161611110.350.35
194.3MA0.000.00+2.00+2.00192011110.30.3
203.6FA0.100.20+1.50+1.75202011110.40.4
C. Open-angle glaucoma
169FCBE0.320.18+0.25+0.5141612120.80.8TRAB(RE)
265MCRE0.160.20PlanoPlano201912120.850.5
376MCBE0.450.20+1+1222212120.50.7
476MCBE0.360.2PlanoPlano161512120.60.5
559MCBE0.100.10+0.25Plano121512120.70.8
669FABE0.100.10PlanoPlano181812120.80.8
756MCBE0.140.22PlanoPlano151612120.80.65TRAB(BE)
866MCBE0.140.16PlanoPlano131112120.60.7
972MCBE0.360.22PlanoPlano141412120.70.8
1060MCBE0.240.20PlanoPlano161712120.60.5
D. Healthy adults (controls for open-angle glaucoma)
177MC0.100.10Plano+0.25191912120.40.4
254MC0.200.10Plano+0.25171612120.350.4
360MC0.100.10Plano+0.50141412120.40.4
471FA0.200.20+0.75Plano121212120.40.4
566FC0.200.10+0.50Plano161612120.30.3
672MC0.100.10PlanoPlano121412120.50.5
757MC0.100.20PlanoPlano192012120.40.4
871MC0.100.20PlanoPlano181812120.30.4
969MC0.200.10PlanoPlano161612120.40.4
1072MC0.100.10PlanoPlano202012120.50.45
  • IOP was measured at the date when optical coherence tomography was done.

  • BE, both eyes; BT, Baelvedt tube; C, Caucasian; CC, Cardiff cards (in all other participants, Kay pictures or Snellen test was used); CL, cyclodiode laser; F, female; FF, following and fixing; G, goniotomy; IOP, intraocular pressure; LE, left eye; M, male; PL, perception of light; PL, preferential looking; RE, right eye; SE, spherical equivalent; TRAB, trabeculectomy.